GSK Malaria Vaccine Gets Landmark Clearance For Use In Africa
WHO Recommendation Takes Account Of 2015 EMA Scientific Opinion
Mosquirix is set for much wider availability in sub-Saharan Africa thanks to positive results from a pilot program in Ghana, Kenya and Malawi. The next step is deciding how to fund the vaccine’s rollout over the coming years.
